Genomictree Inc. (KOSDAQ:228760)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cancer Molecular Diagnosis Business	2.20B	1.82B	1.78B	2.30B	166.02M
Cancer Molecular Diagnosis Business Growth	20.71%	2.45%	-22.72%	1285.70%	174.84%
Genomic Analysis and Other Business	163.41M	1.60B	28.09B	2.84B	1.07B
Genomic Analysis and Other Business Growth	-89.76%	-94.32%	889.33%	164.63%	384.96%
Total	2.36B	3.42B	29.87B	5.14B	1.24B
Total Growth	-30.89%	-88.56%	481.09%	314.87%	339.89%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Korea	2.34B	1.87B	1.82B	398.06M	310.47M
Korea Growth	24.85%	2.90%	357.30%	28.21%	13.57%
China	-	-	-	2.00B	-
Others	23.77M	14.85M	11.16M	-	-
Others Growth	60.01%	33.10%	-	-	-
USA	-	1.53B	28.03B	2.74B	928.38M
USA Growth	-	-94.54%	922.56%	195.31%	11138.12%
Total	2.36B	3.42B	29.87B	5.14B	1.24B
Total Growth	-30.89%	-88.56%	481.09%	314.87%	339.89%

Source: S&P Global Market Intelligence.